Natco Pharma RX
FDA Approved Drugs

Natco Pharma RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 55
  • Latest Approval Date Jun 01, 2026
  • Data Source FDA
  • First Approval Date Jun 25, 2007
All
147
View
Unclassified
5
View
Discontinued
86
View
OTC
1
View
RX
55
View
Company Overview

Company

Natco Pharma RX

Country

India

Website

Visit Website

Email

Social Profiles

LinkedIn
Company Snapshot

Natco Pharma RX

Banjara Hills, Hyderabad-500 034

India

www.natcopharma.co.in/ View on Map
FDA Approved Drug Records ( 55 records )
2015
15 Apr
RX Application: 200739

Drug Name

ALPRAZOLAM

Product Number

1

Dosage Form

-

Strength

0.25MG

Approval Date

2015-04-15

200739 / 1

Active Ingredient

ALPRAZOLAM

Application Number

200739

Product Number

1

Dosage Form

-

Strength

0.25MG

Approval Date

2015-04-15

Regulatory Status

RX

2015
15 Apr
RX Application: 200739

Drug Name

ALPRAZOLAM

Product Number

2

Dosage Form

-

Strength

0.5MG

Approval Date

2015-04-15

200739 / 2

Active Ingredient

ALPRAZOLAM

Application Number

200739

Product Number

2

Dosage Form

-

Strength

0.5MG

Approval Date

2015-04-15

Regulatory Status

RX

2015
15 Apr
RX Application: 200739

Drug Name

ALPRAZOLAM

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2015-04-15

200739 / 3

Active Ingredient

ALPRAZOLAM

Application Number

200739

Product Number

3

Dosage Form

-

Strength

1MG

Approval Date

2015-04-15

Regulatory Status

RX

2015
15 Apr
RX Application: 200739

Drug Name

ALPRAZOLAM

Product Number

4

Dosage Form

-

Strength

2MG

Approval Date

2015-04-15

200739 / 4

Active Ingredient

ALPRAZOLAM

Application Number

200739

Product Number

4

Dosage Form

-

Strength

2MG

Approval Date

2015-04-15

Regulatory Status

RX

2010
28 Jun
RX Application: 79220

Drug Name

ANASTROZOLE

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2010-06-28

79220 / 1

Active Ingredient

ANASTROZOLE

Application Number

79220

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2010-06-28

Regulatory Status

RX

2016
28 Nov
RX Application: 202768

Drug Name

ARMODAFINIL

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2016-11-28

202768 / 1

Active Ingredient

ARMODAFINIL

Application Number

202768

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2016-11-28

Regulatory Status

RX

2016
28 Nov
RX Application: 202768

Drug Name

ARMODAFINIL

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2016-11-28

202768 / 2

Active Ingredient

ARMODAFINIL

Application Number

202768

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2016-11-28

Regulatory Status

RX

2016
28 Nov
RX Application: 202768

Drug Name

ARMODAFINIL

Product Number

3

Dosage Form

-

Strength

250MG

Approval Date

2016-11-28

202768 / 3

Active Ingredient

ARMODAFINIL

Application Number

202768

Product Number

3

Dosage Form

-

Strength

250MG

Approval Date

2016-11-28

Regulatory Status

RX

2017
28 Sep
RX Application: 202768

Drug Name

ARMODAFINIL

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2017-09-28

202768 / 4

Active Ingredient

ARMODAFINIL

Application Number

202768

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2017-09-28

Regulatory Status

RX

2017
28 Sep
RX Application: 202768

Drug Name

ARMODAFINIL

Product Number

5

Dosage Form

-

Strength

200MG

Approval Date

2017-09-28

202768 / 5

Active Ingredient

ARMODAFINIL

Application Number

202768

Product Number

5

Dosage Form

-

Strength

200MG

Approval Date

2017-09-28

Regulatory Status

RX

2017
23 Jun
RX Application: 207234

Drug Name

AZACITIDINE

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

2017-06-23

207234 / 1

Active Ingredient

AZACITIDINE

Application Number

207234

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

2017-06-23

Regulatory Status

RX

2025
05 Feb
RX Application: 213154

Drug Name

BOSENTAN

Product Number

1

Dosage Form

-

Strength

32MG

Approval Date

2025-02-05

213154 / 1

Active Ingredient

BOSENTAN

Application Number

213154

Product Number

1

Dosage Form

-

Strength

32MG

Approval Date

2025-02-05

Regulatory Status

RX

2014
28 Oct
RX Application: 90988

Drug Name

CARISOPRODOL

Product Number

1

Dosage Form

-

Strength

350MG

Approval Date

2014-10-28

90988 / 1

Active Ingredient

CARISOPRODOL

Application Number

90988

Product Number

1

Dosage Form

-

Strength

350MG

Approval Date

2014-10-28

Regulatory Status

RX

2011
21 Jan
RX Application: 90612

Drug Name

CHLOROQUINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2011-01-21

90612 / 1

Active Ingredient

CHLOROQUINE PHOSPHATE

Application Number

90612

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2011-01-21

Regulatory Status

RX

2011
21 Jan
RX Application: 91621

Drug Name

CHLOROQUINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2011-01-21

91621 / 1

Active Ingredient

CHLOROQUINE PHOSPHATE

Application Number

91621

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2011-01-21

Regulatory Status

RX

2026
01 Jun
RX Application: 217085

Drug Name

ERIBULIN MESYLATE

Product Number

1

Dosage Form

-

Strength

1MG/2ML (0.5MG/ML)

Approval Date

2026-06-01

217085 / 1

Active Ingredient

ERIBULIN MESYLATE

Application Number

217085

Product Number

1

Dosage Form

-

Strength

1MG/2ML (0.5MG/ML)

Approval Date

2026-06-01

Regulatory Status

RX

2025
28 Jan
RX Application: 217640

Drug Name

EVEROLIMUS

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2025-01-28

217640 / 1

Active Ingredient

EVEROLIMUS

Application Number

217640

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2025-01-28

Regulatory Status

RX

2025
28 Jan
RX Application: 217640

Drug Name

EVEROLIMUS

Product Number

2

Dosage Form

-

Strength

3MG

Approval Date

2025-01-28

217640 / 2

Active Ingredient

EVEROLIMUS

Application Number

217640

Product Number

2

Dosage Form

-

Strength

3MG

Approval Date

2025-01-28

Regulatory Status

RX

2025
28 Jan
RX Application: 217640

Drug Name

EVEROLIMUS

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2025-01-28

217640 / 3

Active Ingredient

EVEROLIMUS

Application Number

217640

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2025-01-28

Regulatory Status

RX

2023
31 May
RX Application: 212827

Drug Name

GEFITINIB

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2023-05-31

212827 / 1

Active Ingredient

GEFITINIB

Application Number

212827

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2023-05-31

Regulatory Status

RX

2016
20 Jun
RX Application: 91413

Drug Name

GLYCOPYRROLATE

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2016-06-20

91413 / 1

Active Ingredient

GLYCOPYRROLATE

Application Number

91413

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2016-06-20

Regulatory Status

RX

2016
20 Jun
RX Application: 91413

Drug Name

GLYCOPYRROLATE

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2016-06-20

91413 / 2

Active Ingredient

GLYCOPYRROLATE

Application Number

91413

Product Number

2

Dosage Form

-

Strength

2MG

Approval Date

2016-06-20

Regulatory Status

RX

2009
22 Jun
RX Application: 78969

Drug Name

GRANISETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2009-06-22

78969 / 1

Active Ingredient

GRANISETRON HYDROCHLORIDE

Application Number

78969

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2009-06-22

Regulatory Status

RX

2026
17 Feb
RX Application: 216921

Drug Name

IDELALISIB

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-02-17

216921 / 1

Active Ingredient

IDELALISIB

Application Number

216921

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2026-02-17

Regulatory Status

RX

2026
17 Feb
RX Application: 216921

Drug Name

IDELALISIB

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2026-02-17

216921 / 2

Active Ingredient

IDELALISIB

Application Number

216921

Product Number

2

Dosage Form

-

Strength

150MG

Approval Date

2026-02-17

Regulatory Status

RX

2019
01 Mar
RX Application: 207818

Drug Name

IMATINIB MESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2019-03-01

207818 / 1

Active Ingredient

IMATINIB MESYLATE

Application Number

207818

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2019-03-01

Regulatory Status

RX

2019
01 Mar
RX Application: 207818

Drug Name

IMATINIB MESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2019-03-01

207818 / 2

Active Ingredient

IMATINIB MESYLATE

Application Number

207818

Product Number

2

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2019-03-01

Regulatory Status

RX

2012
18 Dec
RX Application: 201921

Drug Name

LANSOPRAZOLE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2012-12-18

201921 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

201921

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2012-12-18

Regulatory Status

RX

2012
18 Dec
RX Application: 201921

Drug Name

LANSOPRAZOLE

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2012-12-18

201921 / 2

Active Ingredient

LANSOPRAZOLE

Application Number

201921

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2012-12-18

Regulatory Status

RX

2017
11 Aug
RX Application: 90978

Drug Name

LANTHANUM CARBONATE

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2017-08-11

90978 / 1

Active Ingredient

LANTHANUM CARBONATE

Application Number

90978

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2017-08-11

Regulatory Status

RX

2017
11 Aug
RX Application: 90978

Drug Name

LANTHANUM CARBONATE

Product Number

2

Dosage Form

-

Strength

EQ 750MG BASE

Approval Date

2017-08-11

90978 / 2

Active Ingredient

LANTHANUM CARBONATE

Application Number

90978

Product Number

2

Dosage Form

-

Strength

EQ 750MG BASE

Approval Date

2017-08-11

Regulatory Status

RX

2017
11 Aug
RX Application: 90978

Drug Name

LANTHANUM CARBONATE

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE

Approval Date

2017-08-11

90978 / 3

Active Ingredient

LANTHANUM CARBONATE

Application Number

90978

Product Number

3

Dosage Form

-

Strength

EQ 1GM BASE

Approval Date

2017-08-11

Regulatory Status

RX

2020
29 Sep
RX Application: 203007

Drug Name

LAPATINIB DITOSYLATE

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2020-09-29

203007 / 1

Active Ingredient

LAPATINIB DITOSYLATE

Application Number

203007

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2020-09-29

Regulatory Status

RX

2011
03 Jun
RX Application: 200161

Drug Name

LETROZOLE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2011-06-03

200161 / 1

Active Ingredient

LETROZOLE

Application Number

200161

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2011-06-03

Regulatory Status

RX

2019
30 Apr
RX Application: 211604

Drug Name

NITROGLYCERIN

Product Number

1

Dosage Form

-

Strength

0.3MG

Approval Date

2019-04-30

211604 / 1

Active Ingredient

NITROGLYCERIN

Application Number

211604

Product Number

1

Dosage Form

-

Strength

0.3MG

Approval Date

2019-04-30

Regulatory Status

RX

2019
30 Apr
RX Application: 211604

Drug Name

NITROGLYCERIN

Product Number

2

Dosage Form

-

Strength

0.4MG

Approval Date

2019-04-30

211604 / 2

Active Ingredient

NITROGLYCERIN

Application Number

211604

Product Number

2

Dosage Form

-

Strength

0.4MG

Approval Date

2019-04-30

Regulatory Status

RX

2019
30 Apr
RX Application: 211604

Drug Name

NITROGLYCERIN

Product Number

3

Dosage Form

-

Strength

0.6MG

Approval Date

2019-04-30

211604 / 3

Active Ingredient

NITROGLYCERIN

Application Number

211604

Product Number

3

Dosage Form

-

Strength

0.6MG

Approval Date

2019-04-30

Regulatory Status

RX

2007
25 Jun
RX Application: 77851

Drug Name

ONDANSETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2007-06-25

77851 / 1

Active Ingredient

ONDANSETRON HYDROCHLORIDE

Application Number

77851

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE

Approval Date

2007-06-25

Regulatory Status

RX

2007
25 Jun
RX Application: 77851

Drug Name

ONDANSETRON HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 8MG BASE

Approval Date

2007-06-25

77851 / 2

Active Ingredient

ONDANSETRON HYDROCHLORIDE

Application Number

77851

Product Number

2

Dosage Form

-

Strength

EQ 8MG BASE

Approval Date

2007-06-25

Regulatory Status

RX

2016
03 Aug
RX Application: 202595

Drug Name

OSELTAMIVIR PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2016-08-03

202595 / 1

Active Ingredient

OSELTAMIVIR PHOSPHATE

Application Number

202595

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2016-08-03

Regulatory Status

RX

2016
03 Aug
RX Application: 202595

Drug Name

OSELTAMIVIR PHOSPHATE

Product Number

2

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2016-08-03

202595 / 2

Active Ingredient

OSELTAMIVIR PHOSPHATE

Application Number

202595

Product Number

2

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2016-08-03

Regulatory Status

RX

2016
03 Aug
RX Application: 202595

Drug Name

OSELTAMIVIR PHOSPHATE

Product Number

3

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2016-08-03

202595 / 3

Active Ingredient

OSELTAMIVIR PHOSPHATE

Application Number

202595

Product Number

3

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2016-08-03

Regulatory Status

RX

2023
24 Oct
RX Application: 218024

Drug Name

SUNITINIB MALATE

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE

Approval Date

2023-10-24

218024 / 1

Active Ingredient

SUNITINIB MALATE

Application Number

218024

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE

Approval Date

2023-10-24

Regulatory Status

RX

2023
24 Oct
RX Application: 218024

Drug Name

SUNITINIB MALATE

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2023-10-24

218024 / 2

Active Ingredient

SUNITINIB MALATE

Application Number

218024

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2023-10-24

Regulatory Status

RX

2023
24 Oct
RX Application: 218024

Drug Name

SUNITINIB MALATE

Product Number

3

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2023-10-24

218024 / 3

Active Ingredient

SUNITINIB MALATE

Application Number

218024

Product Number

3

Dosage Form

-

Strength

EQ 37.5MG BASE

Approval Date

2023-10-24

Regulatory Status

RX

2023
24 Oct
RX Application: 218024

Drug Name

SUNITINIB MALATE

Product Number

4

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2023-10-24

218024 / 4

Active Ingredient

SUNITINIB MALATE

Application Number

218024

Product Number

4

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2023-10-24

Regulatory Status

RX

2023
15 May
RX Application: 209555

Drug Name

TERIFLUNOMIDE

Product Number

1

Dosage Form

-

Strength

7MG

Approval Date

2023-05-15

209555 / 1

Active Ingredient

TERIFLUNOMIDE

Application Number

209555

Product Number

1

Dosage Form

-

Strength

7MG

Approval Date

2023-05-15

Regulatory Status

RX

2023
15 May
RX Application: 209555

Drug Name

TERIFLUNOMIDE

Product Number

2

Dosage Form

-

Strength

14MG

Approval Date

2023-05-15

209555 / 2

Active Ingredient

TERIFLUNOMIDE

Application Number

209555

Product Number

2

Dosage Form

-

Strength

14MG

Approval Date

2023-05-15

Regulatory Status

RX

2026
24 Apr
RX Application: 213267

Drug Name

THALIDOMIDE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2026-04-24

213267 / 2

Active Ingredient

THALIDOMIDE

Application Number

213267

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2026-04-24

Regulatory Status

RX

2026
24 Apr
RX Application: 213267

Drug Name

THALIDOMIDE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2026-04-24

213267 / 3

Active Ingredient

THALIDOMIDE

Application Number

213267

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2026-04-24

Regulatory Status

RX

2026
24 Apr
RX Application: 213267

Drug Name

THALIDOMIDE

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2026-04-24

213267 / 4

Active Ingredient

THALIDOMIDE

Application Number

213267

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

2026-04-24

Regulatory Status

RX

2023
13 Jun
RX Application: 214008

Drug Name

TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE

Product Number

1

Dosage Form

-

Strength

EQ 6.14MG BASE;15MG

Approval Date

2023-06-13

214008 / 1

Active Ingredient

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

Application Number

214008

Product Number

1

Dosage Form

-

Strength

EQ 6.14MG BASE;15MG

Approval Date

2023-06-13

Regulatory Status

RX

2023
13 Jun
RX Application: 214008

Drug Name

TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE

Product Number

2

Dosage Form

-

Strength

EQ 8.19MG BASE;20MG

Approval Date

2023-06-13

214008 / 2

Active Ingredient

TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE

Application Number

214008

Product Number

2

Dosage Form

-

Strength

EQ 8.19MG BASE;20MG

Approval Date

2023-06-13

Regulatory Status

RX

2010
17 Nov
RX Application: 91630

Drug Name

TRIHEXYPHENIDYL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2010-11-17

91630 / 1

Active Ingredient

TRIHEXYPHENIDYL HYDROCHLORIDE

Application Number

91630

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2010-11-17

Regulatory Status

RX

2010
17 Nov
RX Application: 91630

Drug Name

TRIHEXYPHENIDYL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2010-11-17

91630 / 2

Active Ingredient

TRIHEXYPHENIDYL HYDROCHLORIDE

Application Number

91630

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2010-11-17

Regulatory Status

RX

Related Databases
  • FDA Inspections
    10 View
  • EDQM CEP
    14 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    45 View
  • FDA Approved Drugs Database
    147 View
Drug Status Breakdown
55 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ALPRAZOLAM

Application Number

200739

Product Number

1

Active Ingredient

ALPRAZOLAM

Dosage Form

-

Strength

0.25MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit